Key Points

- Analyst recommendations can influence stock prices
- Abbott's new over-the-counter continuous glucose monitor, Lingo™, is available in the U.S.
- Lingo™ is designed for adults without diabetes seeking health and wellness improvements
- The biosensor provides real-time glucose data and personal coaching insights
- Abbott's strong performance in Core Diagnostics and EPD businesses is expected to continue

Abbott Laboratories (ABT) has recently caught the attention of investors, with Zacks.com users showing interest in the company. Analyst recommendations play a significant role in investors' decision-making processes when it comes to buying, selling, or holding a stock. These recommendations can impact a stock's price, making them crucial for investors to consider.

In response to the growing demand for health and wellness solutions, Abbott has launched its over-the-counter continuous glucose monitoring system, Lingo™, in the United States. This biosensor is the first of its kind, catering to individuals without diabetes who are looking to enhance their overall health and wellness.

Lingo™ provides users with real-time glucose data and personalized coaching insights, helping them understand how their body reacts to nutrition, exercise, and daily stressors. The device can be purchased without a prescription, offering convenience and accessibility to those wanting to make positive lifestyle changes.

Abbott's foray into the over-the-counter continuous glucose monitor market marks a transformative move for the company. By offering Lingo™ to adults seeking to improve their health and wellness, Abbott is tapping into a growing demand for self-care and preventative healthcare solutions.

In addition to its consumer-focused offerings, Abbott's strong performance in Core Diagnostics and EPD businesses is expected to drive growth in the upcoming quarters. With a solid foundation in key sectors, Abbott continues to be a top choice for investors looking for stability and potential returns in the healthcare industry.

As Abbott continues to innovate and expand its product offerings, investors may find it worthwhile to keep ABT stock in their portfolios. The launch of Lingo™ and the company's strong performance in core business areas position Abbott for continued success in the healthcare market.

For more information:

Up/Down Rally

Price Distribution

Analyst Recommendations

Earning Price Impact Analysis

Seasonality